Live Breaking News & Updates on Harlanm Krumholz Yale

 E-Mail
NEW YORK, NY (Feb. 26, 2021) People who took statins to lower cholesterol were approximately 50% less likely to die if hospitalized for COVID-19, a study by physicians at Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian has found.
Our study is one of the larger studies confirming this hypothesis and the data lay the groundwork for future randomized clinical trials that are needed to confirm the benefit of statins in COVID-19,  says Aakriti Gupta, MD, a cardiologist at NewYork-Presbyterian/Columbia University Irving Medical Center and one of the co-lead authors of the study.
If their beneficial effect bears out in randomized clinical trials, statins could potentially prove to be a low-cost and effective therapeutic strategy for COVID-19, adds co-lead author Mahesh V. Madhavan, MD, also a cardiologist at NewYork-Presbyterian/Columbia University Irving Medical Center. ....

New York , United States , Jonathan Platt , Timothyj Poterucha , Shayann Nouri , Aakriti Gupta , Jessicaa Hennessey , Ajayj Kirtane , Behnood Bikdeli , Christina Eckhardt , Sahila Parikh , Daniel Brodie , Matthewj Cummings , Ersiliam Defilippis , Jianhua Li , Daniel Burkhoff , Laruens Ranard , Maheshv Madhavan , Harlanm Krumholz Yale , Sanjums Sethi , Pierre Elias , Nir Uriel , Claudia Boyle , Allan Schwartz , Matthew Lawlor , Nature Communications ,